Suchergebnisse - "Grønbaek, Henning"

PubPharm (13)

1

Current perspectives on the pathophysiology of metabolic associated fatty liver disease : are macrophages a viable target for therapy?

enthalten in: Expert review of gastroenterology & hepatology | 2021

von Kjær, M. | George, J. | Kazankov, K. | +1

2

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension

enthalten in: Frontiers in physiology | 2021

von Ørntoft, N. | Blé, M. | Baiges, A. | +8

3

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease

enthalten in: Frontiers in medicine | 2020

von Kazankov, K. | Rosso, C. | Younes, R. | +6

4

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis

enthalten in: Frontiers in medicine | 2020

von Gantzel, R. | Kjær, M. | Laursen, T. | +4

5

Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose

enthalten in: Scandinavian journal of gastroenterology | 2019

von Siggaard, C. | Kazankov, K. | Rødgaard-Hansen, S. | +4

6

The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation

enthalten in: Journal of clinical and experimental hepatology | 2019

von Thomsen, K. | Robertson, F. | Holland-Fischer, P. | +5

7

Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology

enthalten in: Scandinavian journal of gastroenterology | 2018

von Lund Laursen, T. | Brøckner Siggard, C. | Kazankov, K. | +12

8

Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

enthalten in: Journal of gastroenterology and hepatology | 2018

von Laursen, T. | Wong, G. | Kazankov, K. | +6

9

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes

enthalten in: Molecular therapy. Methods & clinical development | 2017

von Svendsen, P. | Graversen, J. | Etzerodt, A. | +7

10

The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Kazankov, K. | Barrera, F. | Møller, H. | +11

ErratumIn: Liver Int. 2017 Nov;37(11):1745. - PMID 29065254